BTIG downgraded Exact Sciences (EXAS) to Neutral from Buy after Abbott (ABT) announced a deal to acquire Exact for $105 per share. The premium “caught us by surprise,” but the firm thinks this is “a great outcome” for Exact and “a good deal” for Abbott, the analyst tells investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS: